Helen C. Lockhart, PhD
Shareholder
| Biotechnology
Overview
Helen Lockhart's practice involves strategic counseling on development and management of domestic and international intellectual property rights for a variety of clients, including universities, smaller and mid-sized companies, start-ups, and entrepreneurs.
Helen has broad experience in prosecuting biotechnology patents relating to immune response modulators, drug delivery, catalytic molecules, antibodies, fluorescence based micro- and nano-analysis, cell culture, mass spectrometry, nucleic acid sequencing, polymer-based and biological-based drug delivery systems, antisense nucleic acid therapeutics, peptides, small molecule mimetics, combinatorial libraries, and drug screening assays. She previously served on the firm’s Executive Committee.
Helen’s doctoral research focused on the regulation of cellular growth and differentiation through signal transduction mechanisms.
Experience
- Developed patent portfolio on a platform technology for a biotechnology company resulting in a substantial out-licensing program with major pharmaceutical companies.
Activities
- American Bar Association
- Boston Bar Association
- Boston Intellectual Property Law Association
- Healthcare Businesswomen's Association
- Massachusetts Bar Association
Recognition
Helen has been repeatedly named to the list of Massachusetts Super Lawyers in the field of intellectual property law. She is also named one of Massachusetts Super Lawyers’ top 100 Women Attorneys. In addition, she has been repeatedly named to The Best Lawyers in America®.
Helen has repeatedly been named a "Life Science Star" by LMG Life Sciences. The LMG Life Sciences guide is based on case evidence and interviews with clients and peers from other law firms.
She has also been repeatedly named to Managing IP’s IP Stars list as a Massachusetts Patent Star and has been repeatedly recognized in the IAM Patent 1000: The World’s Leading Patent Professionals.